Symptom improvement in lung cancer patients treated with erlotinib: quality of life analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21 (Q80142699)
Jump to navigation
Jump to search
scientific article published on 01 August 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Symptom improvement in lung cancer patients treated with erlotinib: quality of life analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21 |
scientific article published on 01 August 2006 |
Statements
Symptom improvement in lung cancer patients treated with erlotinib: quality of life analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21 (English)
Andrea Bezjak
Dongsheng Tu
Lesley Seymour
Gary Clark
Aleksandra Trajkovic
Mauro Zukin
Joseph Ayoub
Sergio Lago
Ronaldo de Albuquerque Ribeiro
Alexandra Gerogianni
Arnold Cyjon
Jonathan Noble
Francis Laberge
Raymond Tsz-Tong Chan
David Fenton
Joachim von Pawel
Martin Reck
Frances A Shepherd
National Cancer Institute of Canada Clinical Trials Group Study BR.21
1 August 2006